Proposed issue of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday

THERAPEUTICS LIMITED

of this announcement

A placement or other type of issue

number of +securities proposed to be issued for a placement or other type of issue

to next page for full details of the announcement

1 - Entity and announcement details

THERAPEUTICS LIMITED

(the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote

any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B

of the ASX Listing Rules.

Date of this announcement

The Proposed issue is:

placement or other type of issue

7 - Details of proposed placement or other issue

- Are any of the following approvals required for the placement or other type of issue?

of +securities proposed to be issued

+Security Code and Description

: ORDINARY FULLY PAID

Number of +securities proposed to be issued

working capital and to progress research and development activities.

price details for retail security holders

these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?

& Scale back details

a scale back be applied to this event?

Proposed +issue date

7D - Listing Rule requirements

Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1?

Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under

( i ) How many +securities are proposed to be issued without security holder approval using the entity's 15% placement capacity

under listing rule 7.1?

Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement

capacity under listing rule 7.1A (if applicable)?

Is a party referred to in listing rule 10.11.1 participating in the proposed issue?

Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?

Will any of the +securities to be issued be subject to +voluntary escrow?

7E - Fees and expenses

Will there be a lead manager or broker to the proposed issue?

Is the proposed issue to be underwritten?

Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue

7F - Further Information

Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?

Any other information the entity wishes to provide about the proposed issue